Exagen Inc (XGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 72,084 | 13,164 | N/A | N/A |
| Receivables | 5,715 | 5,952 | N/A | N/A |
| TOTAL | $81,250 | $21,312 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 1,380 | 1,566 | N/A | N/A |
| Intangibles | 5,506 | 5,506 | 0 | 0 |
| Other Non-Current Assets | 174 | 503 | 0 | 0 |
| TOTAL | $7,060 | $7,575 | $N/A | $N/A |
| Total Assets | $88,310 | $28,887 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,476 | 1,279 | 0 | 0 |
| Accrued Expenses | 4,419 | 3,923 | N/A | N/A |
| Other current liabilities | N/A | 3,750 | N/A | N/A |
| TOTAL | $5,895 | $8,952 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 25,854 | 24,617 | N/A | N/A |
| Other Non-Current Liabilities | 638 | 1,807 | 0 | 0 |
| TOTAL | $26,756 | $26,669 | $N/A | $N/A |
| Total Liabilities | $32,651 | $35,621 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 12,627 | N/A | N/A | N/A |
| Common Shares | 13 | N/A | N/A | N/A |
| Retained earnings | -164,602 | -152,564 | N/A | N/A |
| Other shareholders' equity | 0 | 105,232 | 0 | 0 |
| TOTAL | $55,659 | $-6,734 | $N/A | $N/A |
| Total Liabilities And Equity | $88,310 | $28,887 | $0 | $0 |